What Researchers Did
Researchers conducted a systematic review of 545 records to evaluate the potential of whole body cryotherapy (WBC) and hyperbaric oxygen treatment (HBOT) as new biological treatments for depression, ultimately analyzing three clinical trials.
What They Found
Despite analyzing only three clinical trials from 545 initial records, the review suggests that both whole body cryotherapy and hyperbaric oxygen treatment may be effective in treating depression. Whole body cryotherapy showed potential for augmenting antidepressants with a quick effect, while hyperbaric oxygen treatment appeared effective for endogenous depression and somatic symptoms.
What This Means for Canadian Patients
Canadian patients with depression, particularly those with treatment-resistant forms, might eventually benefit from whole body cryotherapy or hyperbaric oxygen treatment as augmentation strategies. However, these therapies are currently considered preliminary and require further robust research before widespread clinical application.
Canadian Relevance
This systematic review does not specify any direct Canadian connection or data relevant to the Canadian healthcare context.
Study Limitations
A significant limitation of this review is the very small number of clinical trials available for analysis regarding the effectiveness of these treatments for depression.